Structural domains of chimeric dopamine-noradrenaline human transporters involved in the Na+- and Cl--dependence of dopamine transport

Molecular Pharmacology

Volumn 58, Issue 6, 2000, Pages 1404-1411

  Syringas, Maria ^a   Janin, François ^a   Mezghanni, Sana ^a   Giros, Bruno ^b   Costentin, Jean ^a   Bonnet, Jean Jacques ^a,c  

^a CNRS   (France)

^b INSERM   (France)

^c IFRMP 23   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; CHLORIDE ION; DOPAMINE TRANSPORTER; ISETHIONIC ACID; NORADRENALINE TRANSPORTER; SODIUM ION; SUCROSE; TROMETAMOL; UNCLASSIFIED DRUG;

ANIMAL CELL; CHIMERA; CONTROLLED STUDY; DOPAMINE UPTAKE; GENE CASSETTE; HUMAN; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; SHORT SURVEY;

EID: 0033673389     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.58.6.1404     Document Type: Short Survey

References (39)

1. 3H]GBR-12935 binding to human cerebral cortex is not to dopamine uptake sites
2. Neurotransmitter transporters: Recent progress
3. + dependence of the neuronal transport of dopamine
4. Kinetic analysis of the chloride dependence of the neuronal uptake of dopamine and effect of anions on the ability of substrates to compete with the binding of the dopamine uptake inhibitor GBR 12783
5. Drugs and the treatment of psychiatric disorders
6. Transmembrane domain I contributes to the permeation pathway for serotonin and ions in the serotonin transporter
7. GBR 12783, a potent and selective inhibiter of dopamine uptake: Biochemical studies in vitro and ex vivo
8. Chimeric dopamine-norepinephrlne transporters delineate structural domains influencing selectivity for catecholamines and 1-methyl-4-phenylpyridinium
9. Structural domains of catecholamine transporter chimeras involved in selective inhibition by antidepressants and psychomotor stimulants
10. A putative model of the dopamine transporter
11. - in transport
12. Molecular characterization of the dopamine transporter
13. Cloning and functional characterization of a cocaine-sensitive dopamine transporter
14. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter
15. Delineation of discrete domains for substrate, cocaine, and tricyclic antidepressant interaction using chimeric dopamine-norepinephrine transporters
16. Stable expression of biogenic amine transporters reveals differences in inhibiter sensitivity, kinetics, and ion dependence
17. Pemeline therapy in college students with attention deficit hyperactivity disorder: A retrospective study
18. Profound neuronal plasticity in response to inactivation of the dopamine transporter
19. Kinetics and block of dopamine uptake in synaptosomes from rat caudate nucleus
20. The dopomine hypothesis of the reinforcing properties of cocaine
21. 126I]RTI-121 binding sites in human striatum and medial temporal lobe
22. A multisubstrate mechanism of striatal dopamine uptake and its inhibition by cocaine
23. Cloned sodium- (and chloride-) dependent high-affinity transporters for GABA, glycine, proline, betaine, taurine, and creatine
24. N-linked oligosaccharides are required for cell surface expression of the norepinephrine transporter but do not influence substrate or inhibitor recognition
25. Expression cloning of a cocaine, and antidepressant-sensitive human noradrenaline transporter
26. Species differences in dopamine-transporters: Postmortem changes and glycosylation differences
27. Neurotransmitter transporter proteins, posttranslational modifications
28. - of cocaine sensitive carrier-mediated efflux of amines from cells transfected with the cloned human catecholamine transporters
29. 3H]GBR 12,935 binding
30. Translocation of dopamine and binding of WIN35,428 measured under identical conditions in cells expressing the cloned haman dopamine transporter
31. Blockade by antidepressants and related compounds of biogenic amines uptake into rat brain synaptosomes: Most antidepressants selectively block norepinephrine uptake
32. Cocaine self-administration in dopamine-transporter knockout mice
33. The relation of the dopamine transporter gene (DAT1) to symptoms of internalizing disorders in children
34. Ian-coupled neurotransmitter transport: Thermodynamic vs. kinetic determinations of stoichiometry
35. Ion dependence of neurotransmitter uptake: Inhibitory effects of ion substitutes
36. Multiple ionic conductances of thehuman dopamine transporter: The actions of dopamine and psychostimulants
37. 125I]RTI-55: In vitro binding and autoradiographic characterization
38. Cognitive neuroscience of attention deficit hyperactivity disorder and hyperkinetic disorder
39. Aryl 1,4-dialk(en)yl--piperazines as selective and very potent inhibitors of dopamine uptake